Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Completed 6Unknown 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 1Gynecologic 1

Conditions

Vomiting 4Postoperative Nausea and Vomiting 2Neoplasms 2Ovarian Neoplasms 1Nausea 1Myofibroma 1Hematologic Neoplasms 1Adenomyosis 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Interventional × ramosetron × Clear all
NCT01788605 2014-12-08

Efficacy Study of Ramosetron in the Setting of Hematopoietic Stem Cell Transplantation

The Catholic University of Korea

Phase 2 Unknown
65 enrolled
Other hematologic neoplasm

Vomiting, Hematologic Neoplasms

NCT02011659 2013-12-13

PONV

National Health Insurance Service Ilsan Hospital

Phase 3 Unknown
128 enrolled
Gynecologic

Ovarian Neoplasms, Vomiting, Postoperative Nausea and Vomiting, Myofibroma, Adenomyosis

NCT01536691 2012-10-03

ROAD

Hallym University Medical Center

Phase 3 Unknown
338 enrolled

Neoplasms, Vomiting

NCT01046461 2012-02-17

RAD

Hallym University Medical Center

Phase 2 Unknown
41 enrolled

Nausea, Neoplasms, Vomiting, Postoperative Nausea and Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡